Year |
Citation |
Score |
2018 |
Chaudhari P, Tian L, Kim A, Zhu Q, Anders R, Schwarz KB, Sharkis S, Ye Z, Jang YY. Transient c-Src suppression during endodermal commitment of human iPSCs results in abnormal profibrotic cholangiocyte-like cells. Stem Cells (Dayton, Ohio). PMID 30471152 DOI: 10.1002/Stem.2950 |
0.384 |
|
2012 |
Chu SH, Heiser D, Li L, Kaplan I, Collector M, Huso D, Sharkis SJ, Civin C, Small D. FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm. Cell Stem Cell. 11: 346-58. PMID 22958930 DOI: 10.1016/J.Stem.2012.05.027 |
0.489 |
|
2012 |
Sharkis SJ, Jones RJ, Civin C, Jang YY. Pluripotent stem cell-based cancer therapy: promise and challenges. Science Translational Medicine. 4: 127ps9. PMID 22461639 DOI: 10.1126/Scitranslmed.3003920 |
0.45 |
|
2012 |
Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, ... ... Sharkis SJ, et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell. 21: 430-46. PMID 22439938 DOI: 10.1016/J.Ccr.2011.12.029 |
0.337 |
|
2012 |
Gerber JM, Smith BD, Ngwang B, Zhang H, Vala MS, Morsberger L, Galkin S, Collector MI, Perkins B, Levis MJ, Griffin CA, Sharkis SJ, Borowitz MJ, Karp JE, Jones RJ. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood. 119: 3571-7. PMID 22262762 DOI: 10.1182/Blood-2011-06-364182 |
0.479 |
|
2012 |
Tsai H, Li H, Neste LV, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RC, Ahuja N, Brock MV, Stearns V, ... ... Sharkis SJ, et al. Abstract 995: Transient low doses of DNA demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells Cancer Research. 72: 995-995. DOI: 10.1158/1538-7445.Am2012-995 |
0.356 |
|
2011 |
Fan J, Robert C, Jang YY, Liu H, Sharkis S, Baylin SB, Rassool FV. Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining. Mutation Research. 713: 8-17. PMID 21718709 DOI: 10.1016/J.Mrfmmm.2011.05.018 |
0.376 |
|
2011 |
Choi SM, Liu H, Chaudhari P, Kim Y, Cheng L, Feng J, Sharkis S, Ye Z, Jang YY. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent Stem cells Blood. 118: 1801-1805. PMID 21628406 DOI: 10.1182/Blood-2011-03-340620 |
0.45 |
|
2011 |
Liu H, Kim Y, Sharkis S, Marchionni L, Jang YY. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Science Translational Medicine. 3: 82ra39. PMID 21562231 DOI: 10.1126/Scitranslmed.3002376 |
0.436 |
|
2011 |
Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W, Gocke CD, Sharkis SJ, Levitsky HI, Jones RJ. Characterization of chronic myeloid leukemia stem cells. American Journal of Hematology. 86: 31-7. PMID 21132730 DOI: 10.1002/Ajh.21915 |
0.483 |
|
2011 |
Gerber JM, Smith BD, Ngwang B, Zhang H, Vala M, Morsberger L, Galkin S, Collector M, Perkins B, Levis MJ, Griffin C, Sharkis SJ, Borowitz MJ, Karp JE, Jones RJ. The Clinical Relevance of Acute Myeloid Leukemia Stem Cells Blood. 118: 240-240. DOI: 10.1182/Blood.V118.21.240.240 |
0.458 |
|
2010 |
Angelini DJ, Su Q, Kolosova IA, Fan C, Skinner JT, Yamaji-Kegan K, Collector M, Sharkis SJ, Johns RA. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) recruits bone marrow-derived cells to the murine pulmonary vasculature Plos One. 5. PMID 20582166 DOI: 10.1371/Journal.Pone.0011251 |
0.423 |
|
2010 |
Liu H, Ye Z, Kim Y, Sharkis S, Jang YY. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology (Baltimore, Md.). 51: 1810-9. PMID 20432258 DOI: 10.1002/Hep.23626 |
0.549 |
|
2010 |
Tsai H, Neste LV, Li H, Cai Y, Robert C, Shin JJ, Pappou E, Yen R, Minn I, Ahuja N, Brock MV, Rassool FV, Jang Y, Sharkis SJ, Matsui W, et al. Abstract LB-88: Transient exposure to low-dose decitabine and azacytidine reprograms cancer cells to produce a prolonged antitumor response Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-88 |
0.336 |
|
2010 |
Xiao L, He L, Sharkis SJ. Screening for self-renewal factors by a combination of mRNA and CGH microarray in human embryonic stem cells Frontiers in Biology. 5: 431-438. DOI: 10.1007/S11515-010-0900-1 |
0.391 |
|
2009 |
Hu R, Mukhina GL, Lee SH, Jones RJ, Englund PT, Brown P, Sharkis SJ, Buckley JT, Brodsky RA. Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma. Experimental Hematology. 37: 423-434.e2. PMID 19302917 DOI: 10.1016/J.Exphem.2009.01.003 |
0.428 |
|
2008 |
Juopperi TA, Sharkis SJ. Isolation of quiescent murine hematopoietic stem cells by homing properties. Methods in Molecular Biology (Clifton, N.J.). 430: 21-30. PMID 18370289 DOI: 10.1007/978-1-59745-182-6_2 |
0.758 |
|
2007 |
Jang YY, Sharkis SJ. Fetal to adult stem cell transition: knocking Sox17 off. Cell. 130: 403-4. PMID 17693249 DOI: 10.1016/J.Cell.2007.07.027 |
0.455 |
|
2007 |
Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 110: 3056-63. PMID 17595331 DOI: 10.1182/Blood-2007-05-087759 |
0.397 |
|
2007 |
Biankin SA, Collector MI, Biankin AV, Brown LJ, Kleeberger W, Devereux WL, Zahnow CA, Baylin SB, Watkins DN, Sharkis SJ, Leach SD. A histological survey of green fluorescent protein expression in 'green' mice: implications for stem cell research. Pathology. 39: 247-51. PMID 17454756 DOI: 10.1080/00313020701230807 |
0.459 |
|
2007 |
Baldwin BR, Li L, Tse KF, Small S, Collector M, Whartenby KA, Sharkis SJ, Racke F, Huso D, Small D. Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease Leukemia. 21: 764-771. PMID 17268528 DOI: 10.1038/sj.leu.2404532 |
0.344 |
|
2007 |
Juopperi TA, Schuler W, Yuan X, Collector MI, Dang CV, Sharkis SJ. Isolation of Bone Marrow-Derived Stem Cells using Density-Gradient Separation Experimental Hematology. 35: 335-341. PMID 17258082 DOI: 10.1016/J.Exphem.2006.09.014 |
0.753 |
|
2007 |
Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, Berman DM, Jenuwein T, Pruitt K, Sharkis SJ, Watkins DN, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genetics. 39: 237-42. PMID 17211412 DOI: 10.1038/Ng1972 |
0.417 |
|
2006 |
Askenasy N, Yaniv I, Stein J, Sharkis SJ. Our perception of developmental plasticity: esse est percipi (to be is to be perceived)? Current Stem Cell Research & Therapy. 1: 85-94. PMID 18220857 |
0.422 |
|
2006 |
Palapattu GS, Meeker A, Harris T, Collector MI, Sharkis SJ, DeMarzo AM, Warlick C, Drake CG, Nelson WG. Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium. The Journal of Urology. 176: 813-8. PMID 16813953 DOI: 10.1016/J.Juro.2006.03.077 |
0.424 |
|
2006 |
Xiao L, Yuan X, Sharkis SJ. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells (Dayton, Ohio). 24: 1476-86. PMID 16456129 DOI: 10.1634/Stemcells.2005-0299 |
0.414 |
|
2006 |
Hu R, Mukhina GL, Collector MI, Lee SH, Jones RJ, Yuan X, Englund PT, Buckley T, Sharkis SJ, Brodsky RA. Silencing of Genes Required for Glycosylphosphatidylinositol Biosynthesis in a Burkitts’ Lymphoma Cell Line (Ramos) and Hematopoietic Stem Cells (HSC). Blood. 108: 1191-1191. DOI: 10.1182/Blood.V108.11.1191.1191 |
0.54 |
|
2005 |
Jang YY, Sharkis SJ. Stem cell plasticity: a rare cell, not a rare event. Stem Cell Reviews. 1: 45-51. PMID 17132874 DOI: 10.1385/Scr:1:1:045 |
0.472 |
|
2005 |
Sharkis SJ. Canadian stem cell scientists take the prize. Cell. 122: 817-9. PMID 16179246 DOI: 10.1016/J.Cell.2005.09.008 |
0.486 |
|
2004 |
Jang YY, Sharkis SJ. Metamorphosis from bone marrow derived primitive stem cells to functional liver cells. Cell Cycle (Georgetown, Tex.). 3: 980-2. PMID 15254402 DOI: 10.4161/Cc.3.8.1018 |
0.557 |
|
2004 |
Collis SJ, Neutzel S, Thompson TL, Swartz MJ, Dillehay LE, Collector MI, Sharkis SJ, DeWeese TL. Hematopoietic progenitor stem cell homing in mice lethally irradiated with ionizing radiation at differing dose rates. Radiation Research. 162: 48-55. PMID 15222777 DOI: 10.1667/Rr3197 |
0.496 |
|
2004 |
Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion Nature Cell Biology. 6: 532-539. PMID 15133469 DOI: 10.1038/Ncb1132 |
0.447 |
|
2003 |
Brümmendorf TH, Orlic D, Fibbe WE, Sharkis S, Kanz L. Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells IV, University of Tübingen, Germany, September 19-21, 2002. Experimental Hematology. 31: 475-82. PMID 12829022 DOI: 10.1016/S0301-472X(03)00073-0 |
0.394 |
|
2003 |
Theise ND, Krause DS, Sharkis S. Comment on "Little evidence for developmental plasticity of adult hematopoietic stem cells". Science (New York, N.Y.). 299: 1317; author reply 1. PMID 12610282 DOI: 10.1126/Science.1078412 |
0.506 |
|
2003 |
Yan F, Collector MI, Tyszko S, Sharkis SJ. Using divisional history to measure hematopoietic stem cell self-renewal and differentiation. Experimental Hematology. 31: 56-64. PMID 12543107 DOI: 10.1016/S0301-472X(02)01012-3 |
0.56 |
|
2002 |
Collis S, Tyszko S, Thompson T, Dillehay L, Collector M, Sharkis S, DeWeese T. Stem cell homing in mice lethally irradiated with differing dose rates of ionizing radiation International Journal of Radiation Oncology*Biology*Physics. 54: 219. DOI: 10.1016/S0360-3016(02)03436-3 |
0.394 |
|
2001 |
Sharkis SJ, Neutzel S, Collector MI. Phenotype and function of hematopoietic stem cells. Annals of the New York Academy of Sciences. 938: 191-4; discussion 19. PMID 11458508 DOI: 10.1111/J.1749-6632.2001.Tb03589.X |
0.522 |
|
2001 |
Brümmendorf TH, Orlic D, Sharkis SJ, Kanz L. Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells III, University of Tübingen, Germany, September 14-16, 2000. Experimental Hematology. 29: 797-802. PMID 11438201 DOI: 10.1016/s0301-472x(01)00664-6 |
0.421 |
|
2001 |
Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105: 369-77. PMID 11348593 DOI: 10.1016/S0092-8674(01)00328-2 |
0.606 |
|
1999 |
Lanzkron SM, Collector MI, Sharkis SJ. Homing of long-term and short-term engrafting cells in vivo. Annals of the New York Academy of Sciences. 872: 48-54; discussion 54. PMID 10372110 DOI: 10.1111/J.1749-6632.1999.Tb08452.X |
0.56 |
|
1999 |
Donnelly DS, Zelterman D, Sharkis S, Krause DS. Functional activity of murine CD34+ and CD34- hematopoietic stem cell populations Experimental Hematology. 27: 788-796. PMID 10340393 DOI: 10.1016/S0301-472X(99)00032-6 |
0.499 |
|
1999 |
Lanzkron SM, Collector MI, Sharkis SJ. Hematopoietic Stem Cell Tracking In Vivo: A Comparison of Short-Term and Long-Term Repopulating Cells Blood. 93: 1916-1921. DOI: 10.1182/Blood.V93.6.1916.406K15_1916_1921 |
0.536 |
|
1998 |
Sharkis S, Kanz L, Brugger W, Orlic D. The fascinating life of hematopoietic stem cells. Nature Medicine. 4: 1118-9. PMID 9771737 DOI: 10.1038/2611 |
0.547 |
|
1998 |
Sharkis SJ. The fountain of youth: can it be transplanted? Nature Medicine. 4: 896-7. PMID 9701238 DOI: 10.1038/Nm0898-896 |
0.343 |
|
1998 |
Noga SJ, Seber A, Davis JM, Berenson RJ, Vogelsang GB, Braine HG, Hess AD, Marcellus D, Miller CA, Sharkis SJ, Goodman SN, Santos GW, Jones RJ. CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment. Journal of Hematotherapy. 7: 151-7. PMID 9597572 DOI: 10.1089/Scd.1.1998.7.151 |
0.459 |
|
1998 |
Bedi A, Sharkis SJ. Mechanisms of cell commitment in myeloid cell differentiation. Current Opinion in Hematology. 2: 12-21. PMID 9371967 DOI: 10.1097/00062752-199502010-00003 |
0.55 |
|
1997 |
Sharkis SJ, Collector MI, Barber JP, Vala MS, Jones RJ, Lansdorp PM, Zanjani ED, Torok-Storb B, Spangrude GJ, Buhring, Lemischka IR. Phenotypic and functional characterization of the hematopoietic stem cell Stem Cells. 15: 41-45. PMID 9368323 DOI: 10.1002/Stem.5530150807 |
0.616 |
|
1997 |
Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C, Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes & Development. 11: 774-85. PMID 9087431 DOI: 10.1101/Gad.11.6.774 |
0.435 |
|
1997 |
Orlic D, Sharkis SJ. The elusive stem cell: How close are we? Stem Cells. 15: 283-284. DOI: 10.1002/Stem.5530150836 |
0.539 |
|
1996 |
Yao SL, Akhtar AJ, McKenna KA, Bedi GC, Sidransky D, Mabry M, Ravi R, Collector MI, Jones RJ, Sharkis SJ, Fuchs EJ, Bedi A. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nature Medicine. 2: 1140-3. PMID 8837615 DOI: 10.1038/Nm1096-1140 |
0.313 |
|
1996 |
Jones R, Collector M, Barber J, Vala M, Fackler M, May W, Griffin C, Hawkins A, Zehnbauer B, Hilton J, Colvin O, Sharkis S. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity Blood. 88: 487-491. DOI: 10.1182/Blood.V88.2.487.Bloodjournal882487 |
0.532 |
|
1994 |
Krause D, Ito T, Fackler M, Smith O, Collector M, Sharkis S, May W. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells Blood. 84: 691-701. DOI: 10.1182/blood.V84.3.691.bloodjournal843691 |
0.479 |
|
1994 |
Krause D, Ito T, Fackler M, Smith O, Collector M, Sharkis S, May W. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells Blood. 84: 691-701. DOI: 10.1182/Blood.V84.3.691.Bloodjournal843691 |
0.556 |
|
1994 |
Bedi A, Zehnbauer B, Barber J, Sharkis S, Jones R. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood. 83: 2038-2044. DOI: 10.1182/Blood.V83.8.2038.2038 |
0.411 |
|
1994 |
Bedi A, Zehnbauer B, Barber J, Sharkis S, Jones R. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood. 83: 2038-2044. DOI: 10.1182/blood.v83.8.2038.2038 |
0.305 |
|
1993 |
Bedi A, Zehnbauer B, Collector M, Barber J, Zicha M, Sharkis S, Jones R. BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia Blood. 81: 2898-2902. DOI: 10.1182/Blood.V81.11.2898.Bloodjournal81112898 |
0.415 |
|
1992 |
Hawkins AL, Jones RJ, Zehnbauer BA, Zicha MS, Collector MJ, Sharkis SJ, Griffin CA. Fluorescence in situ hybridization to determine engraftment status after murine bone marrow transplant Cancer Genetics and Cytogenetics. 64: 145-148. PMID 1486564 DOI: 10.1016/0165-4608(92)90345-9 |
0.424 |
|
1991 |
Seder RA, Paul WE, Dvorak AM, Sharkis SJ, Kagey-Sobotka A, Niv Y, Finkelman FD, Barbieri SA, Galli SJ, Plaut M. Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proceedings of the National Academy of Sciences of the United States of America. 88: 2835-9. PMID 1826367 DOI: 10.1073/Pnas.88.7.2835 |
0.342 |
|
1990 |
Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature. 347: 188-9. PMID 2395470 DOI: 10.1038/347188A0 |
0.605 |
|
1990 |
Sharkis S, Jones R, Bellis M, Demetri G, Griffin J, Civin C, May W. The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors Blood. 76: 716-720. DOI: 10.1182/Blood.V76.4.716.716 |
0.46 |
|
1990 |
Jones R, Sharkis S, Miller C, Rowinsky E, Burke P, May W. Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro Blood. 75: 1319-1323. DOI: 10.1182/Blood.V75.6.1319.Bloodjournal7561319 |
0.411 |
|
1989 |
Rowley S, Jones R, Piantadosi S, Braine H, Colvin O, Davis J, Saral R, Sharkis S, Wingard J, Yeager A. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia Blood. 74: 501-506. DOI: 10.1182/Blood.V74.1.501.501 |
0.468 |
|
1989 |
Jones R, Celano P, Sharkis S, Sensenbrenner L. Two phases of engraftment established by serial bone marrow transplantation in mice Blood. 73: 397-401. DOI: 10.1182/Blood.V73.2.397.Bloodjournal732397 |
0.498 |
|
1989 |
Jones R, Celano P, Sharkis S, Sensenbrenner L. Two phases of engraftment established by serial bone marrow transplantation in mice Blood. 73: 397-401. DOI: 10.1182/blood.V73.2.397.bloodjournal732397 |
0.409 |
|
1989 |
Sieber F, Krueger G, O'Brien J, Schober S, Sensenbrenner L, Sharkis S. Inactivation of Friend erythroleukemia virus and Friend virus- transformed cells by merocyanine 540-mediated photosensitization Blood. 73: 345-350. DOI: 10.1182/Blood.V73.1.345.345 |
0.354 |
|
1988 |
May WS, Sharkis SJ, Esa AH, Gebbia V, Kraft AS, Pettit GR, Sensenbrenner LL. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 84: 8483-7. PMID 3317410 DOI: 10.1073/Pnas.84.23.8483 |
0.482 |
|
1988 |
Sieber F, O'Brien JM, Krueger GJ, Schober SL, Burns WH, Sharkis SJ, Sensenbrenner LL. Antiviral activity of merocyanine 540. Photochemistry and Photobiology. 46: 707-11. PMID 2831550 DOI: 10.1111/J.1751-1097.1987.Tb04836.X |
0.472 |
|
1988 |
Leonard J, May W, Ihle J, Pettit G, Sharkis S. Regulation of hematopoiesis-IV: The role of interleukin-3 and bryostatin 1 in the growth of erythropoietic progenitors from normal and anemic W/Wv mice Blood. 72: 1492-1496. DOI: 10.1182/Blood.V72.5.1492.1492 |
0.487 |
|
1987 |
Sieber F, Stuart RK, Rowley SD, Sharkis SJ, Sensenbrenner LL. Dye-mediated photolysis of normal and neoplastic hematopoietic cells Leukemia Research. 11: 43-49. PMID 3807420 DOI: 10.1016/0145-2126(87)90104-4 |
0.541 |
|
1987 |
Jones R, Sharkis S, Celano P, Colvin O, Rowley S, Sensenbrenner L. Progenitor cell assays predict hematopoietic reconstitution after syngeneic transplantation in mice Blood. 70: 1186-1192. DOI: 10.1182/Blood.V70.4.1186.1186 |
0.463 |
|
1987 |
Jones R, Sharkis S, Celano P, Colvin O, Rowley S, Sensenbrenner L. Progenitor cell assays predict hematopoietic reconstitution after syngeneic transplantation in mice Blood. 70: 1186-1192. DOI: 10.1182/blood.v70.4.1186.1186 |
0.367 |
|
1987 |
Baylin S, Fearon E, Vogelstein B, de Bustros A, Sharkis S, Burke P, Staal S, Nelkin B. Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies Blood. 70: 412-417. DOI: 10.1182/Blood.V70.2.412.Bloodjournal702412 |
0.397 |
|
1987 |
Rowley S, Sharkis S, Hattenburg C, Sensenbrenner L. Culture from human bone marrow of blast progenitor cells with an extensive proliferative capacity Blood. 69: 804-808. DOI: 10.1182/blood.v69.3.804.bloodjournal693804 |
0.492 |
|
1987 |
Rowley S, Sharkis S, Hattenburg C, Sensenbrenner L. Culture from human bone marrow of blast progenitor cells with an extensive proliferative capacity Blood. 69: 804-808. DOI: 10.1182/Blood.V69.3.804.804 |
0.568 |
|
1986 |
Sharkis S, Cremo C, Collector M, Noga S, Donnenberg A. Thymic regulation of hematopoiesis. III: Isolation of helper and suppressor populations using counterflow centrifugal elutriation Blood. 68: 787-789. DOI: 10.1182/Blood.V68.3.787.Bloodjournal683787 |
0.402 |
|
1984 |
LaRussa V, Sieber F, Sensenbrenner L, Sharkis S. Effects of neuraminidase on the regulation of erythropoiesis Blood. 63: 784-788. DOI: 10.1182/blood.V63.4.784.bloodjournal634784 |
0.417 |
|
1984 |
LaRussa V, Sieber F, Sensenbrenner L, Sharkis S. Effects of neuraminidase on the regulation of erythropoiesis Blood. 63: 784-788. DOI: 10.1182/Blood.V63.4.784.Bloodjournal634784 |
0.505 |
|
1983 |
Luk GD, Sharkis SJ, Abeloff MD, McCann PP, Sjoerdsma A, Baylin SB. Polyamine biosynthesis is required for the maintenance of peripheral blood cell elements in the rat. Proceedings of the National Academy of Sciences of the United States of America. 80: 5090-3. PMID 6410400 DOI: 10.1073/Pnas.80.16.5090 |
0.363 |
|
1983 |
Sharkis S, Luk G, Collector M, McCann P, Baylin S, Sensenbrenner L. Regulation of hematopoiesis II: the role of polyamine inhibition on helper or suppressor influences of the thymus Blood. 61: 604-607. DOI: 10.1182/Blood.V61.3.604.604 |
0.508 |
|
1982 |
Sieber F, Sharkis S. Modulation of murine erythropoiesis in vitro by syngeneic thymocytes: interactions of enhancing and suppressing subpopulations with fluorescent anti-theta antibody and polyamino acids Blood. 60: 845-850. DOI: 10.1182/Blood.V60.4.845.845 |
0.469 |
|
1981 |
Wiktor-Jedrzejczak W, Szczylik C, Górnas P, Sharkis SJ, Ahmed A. Haematopoiesis in mice heterozygous for the W trait: defective formation of transient endogenous spleen colonies. Cell and Tissue Kinetics. 14: 211-7. PMID 7471166 DOI: 10.1111/J.1365-2184.1981.Tb00524.X |
0.401 |
|
1980 |
Ahmed A, Wong DM, Thurman GB, Low TL, Goldstein AL, Sharkis SJ, Goldschneider I. T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Annals of the New York Academy of Sciences. 332: 81-94. PMID 316987 DOI: 10.1111/J.1749-6632.1979.Tb47100.X |
0.343 |
|
1980 |
Spivak J, Misiti J, Stuart R, Sharkis S, Sensenbrenner L. Suppression and potentiation of mouse hematopoietic progenitor cell proliferation by ouabain Blood. 56: 315-317. DOI: 10.1182/blood.v56.2.315.bloodjournal562315 |
0.486 |
|
1980 |
Spivak J, Misiti J, Stuart R, Sharkis S, Sensenbrenner L. Suppression and potentiation of mouse hematopoietic progenitor cell proliferation by ouabain Blood. 56: 315-317. DOI: 10.1182/Blood.V56.2.315.315 |
0.562 |
|
1980 |
Sharkis S, Spivak J, Ahmed A, Misiti J, Stuart R, Wiktor-Jedrzejczak W, Sell K, Sensenbrenner L. Regulation of hematopoiesis: helper and suppressor influences of the thymus Blood. 55: 524-527. DOI: 10.1182/blood.V55.3.524.bloodjournal553524 |
0.463 |
|
1980 |
Sharkis S, Spivak J, Ahmed A, Misiti J, Stuart R, Wiktor-Jedrzejczak W, Sell K, Sensenbrenner L. Regulation of hematopoiesis: helper and suppressor influences of the thymus Blood. 55: 524-527. DOI: 10.1182/Blood.V55.3.524.Bloodjournal553524 |
0.544 |
|
1980 |
Sharkis S, Santos G, Colvin M. Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide Blood. 55: 521-523. DOI: 10.1182/blood.V55.3.521.521 |
0.378 |
|
1979 |
Wiktor-Jedrzejczak W, Ahmed A, Sharkis SJ, McKee A, Sell KW. Defective transient endogenous spleen colony formation in S1/S1d mice. Journal of Cellular Physiology. 99: 31-5. PMID 379025 DOI: 10.1002/Jcp.1040990105 |
0.463 |
|
1979 |
Wiktor-Jedrzejczak W, Szczylik C, Gónaś P, Sharkis SJ, Ahmed A. Different marrow cell number requirements for the haemopoietic colony formation and the curve of the W/Wv anemia. Experientia. 35: 546-7. PMID 374109 DOI: 10.1007/BF01922761 |
0.512 |
|
1978 |
Sharkis S, Wiktor-Jedrzejczak W, Ahmed A, Santos G, McKee A, Sell K. Antitheta-sensitive regulatory cell (TSRC) and hematopoiesis: regulation of differentiation of transplanted stem cells in W/Wv anemic and normal mice Blood. 52: 802-817. DOI: 10.1182/Blood.V52.4.802.802 |
0.55 |
|
1978 |
Sharkis S, Wiktor-Jedrzejczak W, Ahmed A, Santos G, McKee A, Sell K. Antitheta-sensitive regulatory cell (TSRC) and hematopoiesis: regulation of differentiation of transplanted stem cells in W/Wv anemic and normal mice Blood. 52: 802-817. DOI: 10.1182/blood.v52.4.802.802 |
0.471 |
|
1977 |
Sharkis SJ, Santos GW. Bone marrow transplantation in a BN rat model of acute myelogenous leukemia (AML) Leukemia Research. 1: 251-252. DOI: 10.1016/0145-2126(77)90040-6 |
0.358 |
|
1972 |
Sharkis SJ, LoBue J, Alexander P, Rakowitz F, Weitz-Hamburger A, Gordon AS. Circadian variations in mouse hematopoiesis. II. Sex differences in mitotic indices of femoral diaphyseal marrow cells. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 138: 494-6. PMID 4107455 DOI: 10.3181/00379727-138-35926 |
0.306 |
|
Show low-probability matches. |